These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28336953)

  • 1. Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor.
    Guida F; Luongo L; Boccella S; Giordano ME; Romano R; Bellini G; Manzo I; Furiano A; Rizzo A; Imperatore R; Iannotti FA; D'Aniello E; Piscitelli F; Sca Rossi F; Cristino L; Di Marzo V; de Novellis V; Maione S
    Sci Rep; 2017 Mar; 7(1):375. PubMed ID: 28336953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects.
    D'Aloia A; Molteni L; Gullo F; Bresciani E; Artusa V; Rizzi L; Ceriani M; Meanti R; Lecchi M; Coco S; Costa B; Torsello A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
    Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
    Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.
    Redlich S; Ribes S; Schütze S; Nau R
    J Neuroinflammation; 2014 Jun; 11():108. PubMed ID: 24927796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palmitoylethanolamide ameliorates neuroinflammation via modulating PPAR-α to promote the functional outcome after intracerebral hemorrhage.
    Zhou G; Fu X; Wang L; Cao Y; Zhuang J; Hu J; Li Y; Xu C; Gao S; Shao A; Wang L
    Neurosci Lett; 2022 Jun; 781():136648. PubMed ID: 35469820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
    Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
    Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
    Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
    Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
    Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G
    Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.
    Franklin A; Parmentier-Batteur S; Walter L; Greenberg DA; Stella N
    J Neurosci; 2003 Aug; 23(21):7767-75. PubMed ID: 12944505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms.
    Cristiano C; Pirozzi C; Coretti L; Cavaliere G; Lama A; Russo R; Lembo F; Mollica MP; Meli R; Calignano A; Mattace Raso G
    Brain Behav Immun; 2018 Nov; 74():166-175. PubMed ID: 30193877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.
    Vaia M; Petrosino S; De Filippis D; Negro L; Guarino A; Carnuccio R; Di Marzo V; Iuvone T
    Eur J Pharmacol; 2016 Nov; 791():669-674. PubMed ID: 27720681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
    Skaper SD; Facci L; Giusti P
    Mol Neurobiol; 2013 Oct; 48(2):340-52. PubMed ID: 23813098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
    Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
    Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
    Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
    J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    De Gregorio D; Manchia M; Carpiniello B; Valtorta F; Nobile M; Gobbi G; Comai S
    J Affect Disord; 2019 Aug; 255():. PubMed ID: 30391203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity.
    Petrosino S; Schiano Moriello A; Verde R; Allarà M; Imperatore R; Ligresti A; Mahmoud AM; Peritore AF; Iannotti FA; Di Marzo V
    J Neuroinflammation; 2019 Dec; 16(1):274. PubMed ID: 31878942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro.
    Cipriano M; Esposito G; Negro L; Capoccia E; Sarnelli G; Scuderi C; De Filippis D; Steardo L; Iuvone T
    CNS Neurol Disord Drug Targets; 2015; 14(7):828-37. PubMed ID: 25801844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmitoylethanolamide in CNS health and disease.
    Mattace Raso G; Russo R; Calignano A; Meli R
    Pharmacol Res; 2014 Aug; 86():32-41. PubMed ID: 24844438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors.
    Aghaei I; Rostampour M; Shabani M; Naderi N; Motamedi F; Babaei P; Khakpour-Taleghani B
    Epilepsy Res; 2015 Nov; 117():23-8. PubMed ID: 26370914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent manner.
    Wang J; Zheng J; Kulkarni A; Wang W; Garg S; Prather PL; Hauer-Jensen M
    Dig Dis Sci; 2014 Nov; 59(11):2693-703. PubMed ID: 24848354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.